KHCM
EW icon

Kirtland Hills Capital Management’s Edwards Lifesciences EW Stock Holding History

Kirtland Hills Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,495
Closed -$333K – 141
2024
Q4 		$333K Sell
4,495
-633
-12% -$44.3K 0.21% 103
2024
Q3 		$338K Sell
5,128
-1,346
-21% -$97.8K 0.19% 107
2024
Q2 		$598K Sell
6,474
-79
-1% -$7K 0.5% 64
2024
Q1 		$558K Buy
+6,553
New +$550K 0.48% 68

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Kirtland Hills Capital Management's EW Position: Q1 2025 in Review

Kirtland Hills Capital Management sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 4,495 shares — an estimated $333K sold.

Kirtland Hills Capital Management first reported a position in EW in Q1 2024 and held it in 4 quarters. The position peaked at $598K in Q2 2024. 1,205 funds tracked by Wall St. Rank hold EW as of Q1 2025.

  • Kirtland Hills Capital Management reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
  • Kirtland Hills Capital Management sold 4,495 Edwards Lifesciences shares in Q1 2025, an estimated $333K.
  • Kirtland Hills Capital Management first reported a position in Edwards Lifesciences in Q1 2024 and held it in 4 quarters.
  • Kirtland Hills Capital Management's Edwards Lifesciences position peaked at $598K in Q2 2024.
  • 1,205 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.

Based on Kirtland Hills Capital Management's 13F filing for Q1 2025, filed 7 May 2025.